BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 15272754)

  • 1. Aspergillosis of the central nervous system: a catastrophic opportunistic infection.
    Pongbhaesaj P; Dejthevaporn C; Tunlayadechanont S; Witoonpanich R; Sungkanuparph S; Vibhagool A
    Southeast Asian J Trop Med Public Health; 2004 Mar; 35(1):119-25. PubMed ID: 15272754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central nervous system aspergillosis in allogeneic stem cell transplant recipients.
    Jantunen E; Volin L; Salonen O; Piilonen A; Parkkali T; Anttila VJ; Paetau A; Ruutu T
    Bone Marrow Transplant; 2003 Feb; 31(3):191-6. PubMed ID: 12621480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poor efficacy of amphotericin B-based therapy in CNS aspergillosis.
    Schwartz S; Ruhnke M; Ribaud P; Reed E; Troke P; Thiel E
    Mycoses; 2007 May; 50(3):196-200. PubMed ID: 17472616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rhino-orbito-cerebral mucormycosis, a retrospective study of 7 cases.
    Santos Gorjón P; Blanco Pérez P; Batuecas Caletrío A; Muñoz Herrera AM; Sánchez González F; de la Fuente Cañibano R
    Acta Otorrinolaringol Esp; 2010; 61(1):48-53. PubMed ID: 20004878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive aspergillosis in a tertiary-care hospital in Thailand.
    Kiertiburanakul S; Thibbadee C; Santanirand P
    J Med Assoc Thai; 2007 May; 90(5):895-902. PubMed ID: 17596043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspergilloma of the brain: an overview.
    Nadkarni T; Goel A
    J Postgrad Med; 2005; 51 Suppl 1():S37-41. PubMed ID: 16519254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of voriconazole in the treatment of central nervous system blastomycosis.
    Ta M; Flowers SA; Rogers PD
    Ann Pharmacother; 2009 Oct; 43(10):1696-700. PubMed ID: 19724015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic MR imaging features of craniocerebral Aspergillosis of sino-nasal origin in immunocompetent patients.
    Siddiqui AA; Bashir SH; Ali Shah A; Sajjad Z; Ahmed N; Jooma R; Enam SA
    Acta Neurochir (Wien); 2006 Feb; 148(2):155-66; discussion 166. PubMed ID: 16283103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis and treatment of invasive aspergillosis infection following orthotopic liver transplantation].
    Yi SH; Chen GH; Lu MQ; Yang Y; Cai CJ; Xu C; Li H; Wang GS; Yi HM
    Zhonghua Wai Ke Za Zhi; 2006 Jul; 44(13):885-8. PubMed ID: 17067477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic granulomatous disease presenting with disseminated intracranial aspergillosis.
    Alsultan A; Williams MS; Lubner S; Goldman FD
    Pediatr Blood Cancer; 2006 Jul; 47(1):107-10. PubMed ID: 15931655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive aspergillosis as an opportunistic infection in nonallografted patients with multiple myeloma: a European Organization for Research and Treatment of Cancer/ Invasive Fungal Infections Cooperative Group and the Intergroupe Français du Myélome.
    Lortholary O; Ascioglu S; Moreau P; Herbrecht R; Marinus A; Casassus P; De Pauw B; Denning DW
    Clin Infect Dis; 2000 Jan; 30(1):41-6. PubMed ID: 10619731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cryptococcosis of the central nervous system. Clinical and diagnostic characteristics].
    Jiménez-Mejías ME; Fernández A; Alfaro E; Regordan C; Pachón Díaz J
    Med Clin (Barc); 1991 Nov; 97(16):604-8. PubMed ID: 1766280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary and secondary fungal infections of the paranasal sinuses: clinical features and treatment outcomes.
    Han DH; An SY; Kim SW; Kim DY; Rhee CS; Lee CH; Min YG
    Acta Otolaryngol Suppl; 2007 Oct; (558):78-82. PubMed ID: 17882575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of intracranial fungal infections in patients with haematological malignancies.
    Mattiuzzi G; Giles FJ
    Br J Haematol; 2005 Nov; 131(3):287-300. PubMed ID: 16225648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved survival in central nervous system aspergillosis: a series of immunocompromised children with leukemia undergoing stereotactic resection of aspergillomas. Report of four cases.
    Middelhof CA; Loudon WG; Muhonen MD; Xavier C; Greene CS
    J Neurosurg; 2005 Oct; 103(4 Suppl):374-8. PubMed ID: 16270691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of brain aspergillosis with voriconazole.
    Tattevin P; Bruneel F; Lellouche F; de Broucker T; Chevret S; Wolff M; Régnier B
    Clin Microbiol Infect; 2004 Oct; 10(10):928-31. PubMed ID: 15373890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amphotericin B lipid complex in the management of invasive aspergillosis in immunocompromised patients.
    Chandrasekar PH; Ito JI
    Clin Infect Dis; 2005 May; 40 Suppl 6():S392-400. PubMed ID: 15809925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on the treatment of cerebral aspergillosis.
    Schwartz S; Thiel E
    Ann Hematol; 2004; 83 Suppl 1():S42-4. PubMed ID: 15124667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central nervous system fungal infection--a report of three cases.
    Das SK; Bhattacharya S; Mitra K; Roy T; Bhattacharya M; Ghorai SP; Das A; Chakraborty A
    J Indian Med Assoc; 2004 Nov; 102(11):634-6, 638, 640 passim. PubMed ID: 15868875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful use of amphotericin B lipid complex in the treatment of cryptococcosis.
    Baddour LM; Perfect JR; Ostrosky-Zeichner L
    Clin Infect Dis; 2005 May; 40 Suppl 6():S409-13. PubMed ID: 15809927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.